From left to right: Debbie Ma, Kathleen Galati, Cassandra Indri, Aparna Baradi, Dr. Bruce Brener, Paula Carbaca Cordero, Robyn Villaruel and Deborah Thompson (not pictured).
Newark, NJ — January 2026 — The Vascular Non-Invasive Laboratory at Newark Beth Israel Medical Center, an RWJBarnabas Health facility, is proud to mark a significant milestone: 30 consecutive years of accreditation by the Intersocietal Accreditation Commission (IAC), a national leader in promoting quality and safety through accreditation of diagnostic imaging and testing facilities.
In September 2025, Newark Beth Israel Medical Center also received a new three-year term IAC accreditation in Vascular Testing in the areas of Extracranial Cerebrovascular Testing, Peripheral Venous Testing, Peripheral Arterial Testing. This latest accreditation demonstrates the facility’s ongoing commitment to providing quality patient care in vascular testing.
“This milestone represents far more than longevity—it reflects our team’s dedication to precision, consistency, and compassionate care,” said Darrell K. Terry, Sr., MHA, MPH, FACHE, FHELA, President and Chief Executive Officer, Newark Beth Israel Medical Center and Children’s Hospital of New Jersey. “For over 30 years, our vascular lab has upheld the highest national standards to ensure patients receive accurate diagnoses and the best possible outcomes.”
Early detection of life-threatening heart disorders, stroke and other disease are possible through vascular testing procedures performed within hospitals, outpatient centers and physicians’ offices.
The Vascular Laboratory at Newark Beth Israel Medical Center was founded in 1973 by vascular surgeon Bruce Brener, MD, now Director of the Vascular Center of RWJBarnabas Health; Director of Vascular Surgery, Fellowship Program, Newark Beth Israel Medical Center. Newark Beth Israel’s Vascular Laboratory was the first in the state of New Jersey.
IAC accreditation is a rigorous process that evaluates every aspect of a vascular lab’s operations, including staff qualifications, physician oversight, imaging protocols, quality assurance, and patient care practices.
“We are extremely proud to recognize the 30-year, first group of accredited vascular testing facilities through the Gold Milestone recognition program. This recognition is a testament to the hard work and dedication of the staff who have consistently demonstrated their commitment to delivering safe, effective, and compassionate care using accreditation as a quality metric,” said Mary Lally, MS, CAE, CEO of the IAC.
This anniversary underscores Newark Beth Israel Medical Center’s broader commitment to clinical excellence and reinforces its role as a trusted provider of advanced cardiovascular and vascular care in the community.
View more information about the Vascular Laboratory and cardiovascular services at Newark Beth Israel Medical Center.
Newark Beth Israel Medical Center, an RWJBarnabas Health facility, is a 665-bed regional care teaching hospital that provides comprehensive health care. Newark Beth Israel is a Top Teaching Hospital and home to one of the nation’s top ten heart transplant centers, which has performed more than 1,100 heart transplants; RWJBarnabas Health’s Heart Failure Treatment and Transplant Program; New Jersey’s only Advanced Lung Disease and Transplant Program and a Valve Center that performs complex cardiac valve procedures, including minimally invasive transcatheter aortic valve replacements (TAVRs). Newark Beth Israel robotic surgery program is the most experienced in northern New Jersey. RWJBarnabas Health and The Frederick B. Cohen, MD, Comprehensive Cancer and Blood Disorders Center at Newark Beth Israel Medical Center and the Healthcare Foundation of New Jersey Breast Health Center, in partnership with Rutgers Cancer Institute of New Jersey — the state’s only NCI-designated Comprehensive Cancer Center — brings a world class team of researchers and specialists to fight alongside you, providing close-to-home access to the latest treatment and clinical trials. Newark Beth Israel also offers many preventive health programs that promote wellness in the community, including The Beth Greenhouse, which provides access to fresh produce and health and wellness education to residents
Newark Beth Israel Medical Center is also home to Children’s Hospital of New Jersey (CHoNJ), which cares for children from birth through adolescence, with more than 30 specialized pediatric services including New Jersey’s largest Valerie Fund Children’s Center for Cancer and Blood Disorders; and the Children’s Heart Center that offers a complete range of medical and surgical treatments for the most complex cardiac abnormalities.
For more information about stroke services at Newark Beth Israel Medical Center, please visit rwjbh.org/newarkbeth
About IAC
The IAC is a nonprofit organization in operation to evaluate and accredit facilities that provide diagnostic imaging, interventional and therapeutic procedures, thus improving the quality of patient care provided in private offices, clinics, and hospitals where such services are performed. The IAC provides accreditation programs for vascular testing, echocardiography, nuclear/PET, MRI, CT/dental CT, carotid stenting, vascular interventional, cardiac electrophysiology, cardiovascular catheterization, and image-guided procedures. The IAC programs for accreditation are dedicated to ensuring quality patient care and promoting health care and all support one common mission: Improving health care through accreditation®. Committed to its mission through a rigorous peer review process, the IAC has granted accreditation to more than 14,000 sites since its inception in 1991. To learn more about IAC, visit intersocietal.org.